FDA
approval
· 2016-04-26
FDA Approved: XTAMPZA ER — Original Application (Collegium Pharmaceutical, Inc.)
Summary
The FDA approved XTAMPZA ER, an extended-release oxycodone product from Collegium Pharmaceutical, for the management of chronic pain in adults requiring around-…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for XTAMPZA ER (OXYCODONE)